Giovannoni, G., Soelberg Sorensen, P., Cook, S., Rammohan, K. W., Rieckmann, P., Comi, G., . . . Vermersch, P. (2019). Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study. Multiple sclerosis, 25(6), 819. https://doi.org/10.1177/1352458518771875
Chicago-Zitierstil (17. Ausg.)Giovannoni, Gavin, Per Soelberg Sorensen, Stuart Cook, Kottil W. Rammohan, Peter Rieckmann, Giancarlo Comi, Fernando Dangond, Christine Hicking, und Patrick Vermersch. "Efficacy of Cladribine Tablets in High Disease Activity Subgroups of Patients with Relapsing Multiple Sclerosis: A Post Hoc Analysis of the CLARITY Study." Multiple Sclerosis 25, no. 6 (2019): 819. https://doi.org/10.1177/1352458518771875.
MLA-Zitierstil (9. Ausg.)Giovannoni, Gavin, et al. "Efficacy of Cladribine Tablets in High Disease Activity Subgroups of Patients with Relapsing Multiple Sclerosis: A Post Hoc Analysis of the CLARITY Study." Multiple Sclerosis, vol. 25, no. 6, 2019, p. 819, https://doi.org/10.1177/1352458518771875.